TP53 and breast cancer: In this study, we partitioned the 750 breast cancer patients into two groups, one with a wild-type TP53 gene (wtTP53) and the other with somatic mutations in the TP53 gene (mTP53), and constructed gene correlation networks (GCNs) enriched with prognostic information.